glp 1 drugs oral list The Great (Oral) GLP-1 Scare GLP-1 Receptor Agonist Shortage: Challenges
Description
RR, relative risk
A., Kushner, R
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
The protocol has not been registered in any platform
Erratum in: N Engl J Med
